Advances in the understanding of Barth syndrome

British Journal of Haematology

Volumn 161, Issue 3, 2013, Pages 330-338

  Aprikyan, Andranik A ^a   Khuchua, Zaza ^b  

^a Institute for Nanotechnology and Stem Cell Biology   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

Author keywords

Apoptosis; Barth syndrome; Cardiomyopathy; Mitochondrial disease; Neutropenia

Indexed keywords

CARDIOLIPIN;

APOPTOSIS; ARTICLE; BACTERIAL INFECTION; BARTH SYNDROME; BONE MARROW CELL; CARDIOMYOPATHY; CLINICAL FEATURE; EXPERIMENTAL MODEL; GENE; GENE FUNCTION; GENE MUTATION; GROWTH RETARDATION; HUMAN; MOLECULAR GENETICS; NEUTROPENIA; NEUTROPHIL; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SEPSIS; TAZ GENE;

ACYLATION; ANIMALS; BACTERIAL INFECTIONS; BARTH SYNDROME; BONE MARROW; CARDIOLIPINS; CHROMOSOMES, HUMAN, X; DISEASE MODELS, ANIMAL; DROSOPHILA MELANOGASTER; DROSOPHILA PROTEINS; FETAL HEART; GENE KNOCKDOWN TECHNIQUES; GROWTH DISORDERS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MICE; MICE, TRANSGENIC; MITOCHONDRIA, HEART; MUTATION; NEUTROPENIA; RNA INTERFERENCE; SEQUENCE DELETION; TRANSCRIPTION FACTORS; ZEBRAFISH; ZEBRAFISH PROTEINS;

EID: 84876189171     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.12271     Document Type: Article

References (87)

1. Acehan, D., Xu, Y., Stokes, D.L. & Schlame, M. (2007) Comparison of lymphoblast mitochondria from normal subjects and patients with Barth syndrome using electron microscopic tomography. Laboratory Investigation, 87, 40-48.
2. Acehan, D., Khuchua, Z., Houtkooper, R.H., Malhotra, A., Kaufman, J., Vaz, F.M., Ren, M., Rockman, H.A., Stokes, D.L. & Schlame, M. (2009) Distinct effects of tafazzin deletion in differentiated and undifferentiated mitochondria. Mitochondrion, 9, 86-95.
3. Acehan, D., Vaz, F., Houtkooper, R.H., James, J., Moore, V., Tokunaga, C., Kulik, W., Wansapura, J., Toth, M.J., Strauss, A. & Khuchua, Z. (2010) Cardiac and skeletal muscle defects in a mouse model of human Barth syndrome. Journal of Biological Chemistry, 286, 899-908.
4. Adwani, S.S., Whitehead, B.F., Rees, P.G., Morris, A., Turnball, D.M., Elliott, M.J. & de Leval, M.R. (1997) Heart transplantation for Barth syndrome. Pediatric Cardiology, 18, 143-145.
5. Aprikyan, A.A., Liles, W.C., Rodger, E., Jonas, M., Chi, E.Y. & Dale, D.C. (2001) Impaired survival of bone marrow hematopoietic progenitor cells in cyclic neutropenia. Blood, 97, 147-153.
6. Aprikyan, A.A., Kutyavin, T., Stein, S., Aprikian, P., Rodger, E., Liles, W.C., Boxer, L.A. & Dale, D.C. (2003) Cellular and molecular abnormalities in severe congenital neutropenia predisposing to leukemia. Exp Hematol., 31, 372-81. Erratum in. Experimental Hematology, 34, 1771-1772.
7. Bachou, T., Giannakopoulos, A., Trapali, C., Vazeou, A. & Kattamis, A. (2009) A novel mutation in the G4.5 (TAZ) gene in a Greek patient with Barth syndrome. Blood Cells, Molecules, and Diseases, 42, 262-264.
8. Ban, T., Heymann, J.A., Song, Z., Hinshaw, J.E. & Chan, D.C. (2010) OPA1 disease alleles causing dominant optic atrophy have defects in cardiolipin-stimulated GTP hydrolysis and membrane tubulation. Human Molecular Genetics, 19, 2113-2122.
9. Barth, P.G., Scholte, H.R., Berden, J.A., Van der Klei-Van Moorsel, J.M., Luyt-Houwen, I.E., Van't Veer-Korthof, E.T., Van der Harten, J.J. & Sobotka-Plojhar, M.A. (1983) An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytes. Journal of the Neurological Sciences, 62, 327-355.
10. Bers, D.M. (2001) Excitation-Contraction Coupling and Cardiac Contractile Force, 2nd edn. Kluwer Academic Publishers, Dordrecht, The Netherlands.
11. Bione, S., D'Adamo, P., Maestrini, E., Gedeon, A.K., Bolhuis, P.A. & Toniolo, D. (1996) A novel X-linked gene, G4.5, is responsible for Barth syndrome. Nature Genetics, 12, 385-389.
12. Bissler, J.J., Tsoras, M., Göring, H.H., Hug, P., Chuck, G., Tombragel, E., McGraw, C., Schlotman, J., Ralston, M.A. & Hug, G. (2002) Infantile dilated X-linked cardiomyopathy, G4.5 mutations, altered lipids, and ultrastructural malformations of mitochondria in heart, liver, and skeletal muscle. Laboratory Investigation, 82, 335-344.
13. Bleyl, S.B., Mumford, B.R., Thompson, V., Carey, J.C., Pysher, T.J., Chin, T.K. & Ward, K. (1997) Neonatal, lethal noncompaction of the left ventricular myocardium is allelic with Barth syndrome. American Journal of Human Genetics, 61, 868-872.
14. Cantlay, A.M., Shokrollahi, K., Allen, J.T., Lunt, P.W., Newbury-Ecob, R.A. & Steward, C.G. (2000) (1999) Genetic analysis of the G4.5 gene in families with suspected Barth syndrome. J Pediatr, 135, 311-315. Erratum in. Journal of Pediatrics, 136, 136.
15. Carlsson, G., Aprikyan, A.A., Tehranchi, R., Dale, D.C., Porwit, A., Hellström-Lindberg, E., Palmblad, J., Henter, J.I. & Fadeel, B. (2004) Kostmann syndrome: severe congenital neutropenia associated with defective expression of Bcl-2, constitutive mitochondrial release of cytochrome c, and excessive apoptosis of myeloid progenitor cells. Blood, 103, 3355-3361.
16. Chen, S., Tarsio, M., Kane, P.M. & Greenberg, M.L. (2008) Cardiolipin mediates cross-talk between mitochondria and the vacuole. Molecular Biology of the Cell, 19, 5047-5058.
17. Chin, T.K., Perloff, J.K., Williams, R.G., Jue, K. & Mohrmann, R. (1990) Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation, 82, 507-513.
18. Claypool, S.M. (2009) Cardiolipin, a critical determinant of mitochondrial carrier protein assembly and function. Biochimica et Biophysica Acta, 1788, 2059-2068.
19. Collins, J.J., Cowan, C., Schlaeger, T.M. & Ross, D.J. (2010) Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Cell Stem Cell, 7, 618-630.
20. Cosson, L., Toutain, A., Simard, G., Kulik, W., Matyas, G., Guichet, A., Blasco, H., Maakaroun-Vermesse, Z., Vaillant, M.C., Le Caignec, C., Chantepie, A. & Labarthe, F. (2012) Barth syndrome in a female patient. Molecular Genetics and Metabolism, 106, 115-120.
21. Cox, G.F., Pulsipher, M., Rothenberg, M., Korson, M. & Kelley, R.I. (1995) Correction of neutropenia in Barth syndrome by G-CSF. American Journal of Human Genetics, 57(Suppl), A177.
22. Dale, D.C., Person, R.E., Bolyard, A.A., Aprikyan, A.G., Bos, C.E., Bonilla, M.A., Boxer, L.A., Kannourakis, G., Ziedler, C., Welte, K., Benson, K.F. & Horwitz, M. (2000) Mutations in the gene encoding neutrophil elastase in congenital and cyclic neutropenia. Blood, 96, 2317-2322.
23. DeVay, R.M., Dominguez-Ramirez, L., Lackner, L.L., Hoppins, S., Stahlberg, H. & Nunnari, J. (2009) Coassembly of Mgm1 isoforms requires cardiolipin and mediates mitochondrial inner membrane fusion. Journal of Cell Biology, 186, 793-803.
24. Devriendt, K., Kim, A.S., Mathijs, G., Frints, S.G., Schwartz, M., Van Den Oord, J.J., Verhoef, G.E., Boogaerts, M.A., Fryns, J.P., You, D., Rosen, M.K. & Vandenberghe, P. (2001) Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nature Genetics, 27, 313-317.
25. Dong, F. & Larner, A.C. (2000) Activation of Akt kinase by granulocyte colony-stimulating factor (G- CSF): evidence for the role of a tyrosine kinase activity distinct from the Janus kinases. Blood, 95, 1656-1662.
26. Dror, Y. & Freedman, M.H. (2001) Shwachman-Diamond syndrome marrow cells show abnormally increased apoptosis mediated through the Fas pathway. Blood, 97, 3011-3016.
27. Dror, Y., Donadieu, J., Koglmeier, J., Dodge, J., Toiviainen-Salo, S., Makitie, O., Kerr, E., Zeidler, C., Shimamura, A., Shah, N., Cipolli, M., Kuijpers, T., Durie, P., Rommens, J., Siderius, L. & Liu, J.M. (2011) Draft consensus guidelines for diagnosis and treatment of Shwachman-Diamond syndrome. Annals of the New York Academy of Sciences, 1242, 40-55.
28. Ferrari, R., Cargnoni, A. & Ceconi, C. (2006) Anti-ischaemic effect of ivabradine. Pharmacological Research, 53, 435-439.
29. Finsterer, J. & Frank, M. (2013) Haematological features in Barth syndrome. Current Opinion in Hematology, 20, 36-40.
30. Fossati, G., Moulding, D.A., Spiller, D.G., Moots, R.J., White, M.R. & Edwards, S.W. (2003) The mitochondrial network of human neutrophils: role in chemotaxis, phagocytosis, respiratory burst activation, and commitment to apoptosis. The Journal of immunology, 170, 1964-1972.
31. Gebert, N., Joshi, A.S., Kutik, S., Becker, T., McKenzie, M., Guan, X.L., Mooga, V.P., Stroud, D.A., Kulkarni, G., Wenk, M.R., Rehling, P., Meisinger, C., Ryan, M.T., Wiedemann, N., Greenberg, M.L. & Pfanner, N. (2009) Mitochondrial cardiolipin involved in outer-membrane protein biogenesis: implications for Barth syndrome. Current Biology, 19, 2133-2139.
32. Gonzalvez, F., Schug, Z.T., Houtkooper, R.H., MacKenzie, E.D., Brooks, D.G., Wanders, R.J., Petit, P.X., Vaz, F.M. & Gottlieb, E. (2008) Cardiolipin provides an essential activating platform for caspase-8 on mitochondria. Journal of Cell Biology, 183, 681-696.
33. Grenda, D.S., Johnson, S.E., Mayer, J.R., McLemore, M.L., Benson, K.F., Horwitz, M. & Link, D.C. (2002) Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis. Blood, 100, 3221-3228.
34. Haines, T.H. & Dencher, N.A. (2002) Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Letters, 528, 35-39.
35. Han, X., Yang, J., Cheng, H., Yang, K., Abendschein, D.R. & Gross, R.W. (2005) Shotgun lipidomics identifies cardiolipin depletion in diabetic myocardium linking altered substrate utilization with mitochondrial dysfunction. Biochemistry, 44, 16684-16694.
36. Harada, M., Qin, Y., Takano, H., Minamino, T., Zou, Y., Toko, H., Ohtsuka, M., Matsuura, K., Sano, M., Nishi, J., Iwanaga, K., Akazawa, H., Kunieda, T., Zhu, W., Hasegawa, H., Kunisada, K., Nagai, T., Nakaya, H., Yamauchi-Takihara, K. & Komuro, I. (2005) G-CSF prevents cardiac remodeling after myocardial infarction by activating the Jak-Stat pathway in cardiomyocytes. Nature Medicine, 11, 305-311.
37. Hastings, R., Steward, C., Tsai-Goodman, B. & Newbury-Ecob, R. (2009) Dysmorphology of Barth syndrome. Clinical Dysmorphology, 18, 185-187.
38. Hodgson, S., Child, A. & Dyson, M. (1987) Endocardial fibroelastosis: possible X-linked inheritance. Journal of Medical Genetics, 24, 210-214.
39. Houtkooper, R.H., Rodenburg, R.J., Thiels, C., van Lenthe, H., Stet, F., Poll-The, B.T., Stone, J.E., Steward, C.G., Wanders, R.J., Smeitink, J., Kulik, W. & Vaz, F.M. (2009) Cardiolipin and monolysocardiolipin analysis in fibroblasts, lymphocytes, and tissues using high-performance liquid chromatography-mass spectrometry as a diagnostic test for Barth syndrome. Analytical Biochemistry, 387, 230-237.
40. Huang, H.P., Chen, P.H., Hwu, W.L., Chuang, C.Y., Chien, Y.H., Stone, L., Chien, C.L., Li, L.T., Chiang, S.C., Chen, H.F., Ho, H.N., Chen, C.H. & Kuo, H.C. (2011) Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification. Human Molecular Genetics, 20, 4851-4864.
41. Ichida, F., Tsubata, S., Bowles, K.R., Haneda, N., Uese, K., Miyawaki, T., Dreyer, W.J., Messina, J., Li, H., Bowles, N.E. & Towbin, J.A. (2001) Novel gene mutations in patients with left ventricular noncompaction or Barth syndrome. Circulation, 103, 1256-1263.
42. Ino, T., Sherwood, W.G., Cutz, E., Benson, L.N., Rose, V. & Freedom, R.M. (1988) Dilated cardiomyopathy with neutropenia, short stature and abnormal carnitine metabolism. Journal of Pediatrics, 113, 511-514.
43. Johnston, J., Kelley, R.I., Feigenbaum, A., Cox, G.F., Iyer, G.S., Funanage, V.L. & Proujansky, R. (1997) Mutation characterization and genotype-phenotype correlation in Barth syndrome. American Journal of Human Genetics, 61, 1053-1058.
44. Kelley, R.I., Clark, B.J., Morton, D.H. & Sherwood, W.G. (1989) X-linked cardiomyopathy, neutropenia, and increasing urinary levels of 3-methylglutaconic and 2-ethylhydracrylic acids. American Journal of Human Genetics, 45(Suppl), A7.
45. Kelley, R.I., Cheatham, J.P., Clark, B.J., Nigro, M.A., Powell, B.R., Sherwood, G.W., Sladky, J.T. & Swisher, W.P. (1991) X-linked dilated cardiomyopathy with neutropenia, growth retardation and 3-methylglutaconic aciduria. Journal of Pediatrics, 119, 738-747.
46. Khryapenkova, T.G., Plotnikov, E.Y., Korotetskaya, M.V., Sukhikh, G.T. & Zorov, D.B. (2008) Heterogeneity of mitochondrial potential as a marker for isolation of pure cardiomyoblast population. Bulletin of Experimental Biology and Medicine, 146, 506-511.
47. Khuchua, Z., Yue, Z., Batts, L. & Strauss, A.W. (2006) A zebrafish model of human Barth syndrome reveals the essential role of neutrope in cardiac development and function. Circulation Research, 99, 201-208.
48. Kiebish, M.A., Han, X., Cheng, H., Chuang, J.H. & Seyfried, T.N. (2008) Cardiolipin and electron transport chain abnormalities in mouse brain tumor mitochondria: lipidomic evidence supporting the Warburg theory of cancer. Journal of Lipid Research, 49, 2545-2556.
49. Klein, C. & Welte, K. (2010) Genetic insights into congenital neutropenia. Clinical Reviews in Allergy and Immunology, 38, 68-74.
50. Klein, C., Grudzien, M., Appaswamy, G., Germeshausen, M., Sandrock, I., Schäffer, A.A., Rathinam, C., Boztug, K., Schwinzer, B., Rezaei, N., Bohn, G., Melin, M., Carlsson, G., Fadeel, B., Dahl, N., Palmblad, J., Henter, J.I., Zeidler, C., Grimbacher, B. & Welte, K. (2007) HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nature Genetics, 39, 86-92.
51. Kohlhaas, M., Liu, T., Knopp, A., Zeller, T., Ong, M.F., Böhm, M., O'Rourke, B. & Maack, C. (2010) Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytes. Circulation, 121, 1606-1613.
52. Koker, M.Y., Sanal, O., de Boer, M., Tezcan, I., Metin, A., Tan, C., Ersoy, F. & Roos, D. (2006) Skewing of X-chromosome inactivation in three generations of carriers with X-linked chronic granulomatous disease within one family. European Journal of Clinical Investigation, 36, 257-264.
53. Kuijpers, T.W., Maianski, N.A., Tool, A.T., Becker, K., Plecko, B., Valianpour, F., Wanders, R.J., Pereira, R., Van Hove, J., Verhoeven, A.J., Roos, D., Baas, F. & Barth, P.G. (2004) Neutrophils in Barth syndrome (BTHS) avidly bind annexin-V in the absence of apoptosis. Blood, 103, 3915-3923.
54. Kulik, W., van Lenthe, H., Stet, F.S., Houtkooper, R.H., Kemp, H., Stone, J.E., Steward, C.G., Wanders, R.J. & Vaz, F.M. (2008) Bloodspot assay using HPLC-tandem mass spectrometry for detection of Barth syndrome. Clinical Chemistry, 54, 371-378.
55. Kutik, S., Rissler, M., Guan, X.L., Guiard, B., Shui, G., Gebert, N., Heacock, P.N., Rehling, P., Dowhan, W., Wenk, M.R., Pfanner, N. & Wiedemann, N. (2008) The translocator maintenance protein Tam41 is required for mitochondrial cardiolipin biosynthesis. Journal of Cell Biology, 183, 1213-1221.
56. Lee, H.J., Mayette, J., Rapoport, S.I. & Bazinet, R.P. (2006) Selective remodeling of cardiolipin fatty acids in the aged rat heart. Lipids in Health and Disease, 5, 2.
57. Lesnefsky, E.J. & Hoppel, C.L. (2008) Cardiolipin as an oxidative target in cardiac mitochondria in the aged rat. Biochimica et Biophysica Acta, 1777, 1020-1027.
58. Lesnefsky, E.J., Chen, Q., Slabe, T.J., Stoll, M.S., Minkler, P.E., Hassan, M.O., Tandler, B. & Hoppel, C.L. (2004) Ischemia, rather than reperfusion, inhibits respiration through cytochrome oxidase in the isolated, perfused rabbit heart: role of cardiolipin. American journal of physiology. Heart and circulatory physiology, 287, H258-H267.
59. Makaryan, V., Kulik, W., Vaz, F.M., Allen, C., Dror, Y., Dale, D.C. & Aprikyan, A.A. (2012) The cellular and molecular mechanisms for neutropenia in Barth syndrome. European Journal of Haematology, 88, 195-209.
60. Malhotra, A., Xu, Y., Ren, M. & Schlame, M. (2009) Formation of molecular species of mitochondrial cardiolipin. 1. A novel transacylation mechanism to shuffle fatty acids between sn-1 and sn-2 positions of multiple phospholipid species. Biochimica et Biophysica Acta, 1791, 314-320.
61. Maniti, O., Lecompte, M.F., Marcillat, O., Desbat, B., Buchet, R., Vial, C. & Granjon, T. (2009) Mitochondrial creatine kinase binding to phospholipid monolayers induces cardiolipin segregation. Biophysical Journal, 96, 2428-2438.
62. Massullo, P., Druhan, L.J., Bunnell, B.A., Hunter, M.G., Robinson, J.M., Marsh, C.B. & Avalos, B.R. (2005) Aberrant subcellular targeting of the G185R neutrophil elastase mutant associated with severe congenital neutropenia induces premature apoptosis of differentiating promyelocytes. Blood, 105, 3397-3404.
63. Minks, J., Robinson, W.P. & Brown, C.J. (2008) A skewed view of X chromosome inactivation. The Journal of Clinical Investigation, 118, 20-23.
64. Nanua, S., Murakami, M., Xia, J., Grenda, D.S., Woloszynek, J., Strand, M. & Link, D.C. (2011) Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane. Blood, 117, 3539-3547.
65. Neustein, H.B., Lurie, P.R., Dahms, B. & Takahashi, M. (1979) An X-linked recessive cardiomyopathy with abnormal mitochondria. Pediatrics, 64, 24-29.
66. Neuwald, A.F. (1997) Barth syndrome may be due to an acyltransferase eficiency. Current Biology, 7, R465-R466.
67. Park, I.H., Zhao, R., West, J.A., Yabuuchi, A., Huo, H., Ince, T.A., Lerou, P.H., Lensch, M.W. & Daley, G.Q. (2008a) Reprogramming of human somatic cells to pluripotency with defined factors. Nature, 451, 141-146.
68. Park, I.H., Arora, N., Huo, H., Maherali, N., Ahfeldt, T., Shimamura, A., Lensch, M.W., Cowan, C., Hochedlinger, K. & Daley, G.Q. (2008b) Disease-specific induced pluripotent stem cells. Cell, 134, 877-886.
69. Phoon, C.K., Acehan, D., Schlame, M., Stokes, D.L., Edelman-Novemsky, I., Yu, D., Xu, Y., Viswanathan, N. & Ren, M. (2012) Tafazzin knockdown in mice leads to a developmental cardiomyopathy with early diastolic dysfunction preceding myocardial noncompaction. Journal of the American Heart Association, 1, jah3-e000455. doi: 10.1161/JAHA.111.000455. Epub 2012 Apr 24.
70. van Raam, B.J., Sluiter, W., de Wit, E., Roos, D., Verhoeven, A.J. & Kuijpers, T.W. (2008) Mitochondrial membrane potential in human neutrophils is maintained by complex III activity in the absence of supercomplex organisation. PLoS ONE, 3, e2013.
71. Renner, L.D. & Weibel, D.B. (2011) Cardiolipin microdomains localize to negatively curved regions of Escherichia coli membranes. Proceedings of the National Academy of Sciences of the USA, 108, 6264-6269.
72. Roberts, A.E., Nixon, C., Steward, C.G., Gauvreau, K., Maisenbacher, M., Fletcher, M., Geva, J., Byrne, B.J. & Spencer, C.T. (2012) The Barth Syndrome Registry: distinguishing disease characteristics and growth data from a longitudinal study. American Journal of Medical Genetics, 158, 2726-2732.
73. Sakamoto, O., Ohura, T., Katsushima, Y., Fujiwara, I., Ogawa, E., Miyabayashi, S. & Iinuma, K. (2001) A novel intronic mutation of the TAZ (G4.5) gene in a patient with Barth syndrome: creation of a 5′ splice donor site with variant GC consensus and elongation of the upstream exon. Human Genetics, 109, 559-563.
74. Schlame, M., Rua, D. & Greenberg, M.L. (2000) The biosynthesis and functional role of cardiolipin. Progress in Lipid Research, 39, 257-288.
75. Schlame, M., Ren, M., Xu, Y., Greenberg, M.L. & Haller, I. (2005) Molecular symmetry in mitochondrial cardiolipins. Chemistry and Physics of Lipids, 138, 38-49.
76. Soustek, M.S., Falk, D.J., Mah, C.S., Toth, M.J., Schlame, M., Lewin, A.S. & Byrne, B.J. (2010) Characterization of a transgenic shRNA induced murine model of tafazzin deficiency. Human Gene Therapy, 22, 865-871.
77. Sparagna, G.C., Johnson, C.A., McCune, S.A., Moore, R.L. & Murphy, R.C. (2005) Quantitation of cardiolipin molecular species in spontaneously hypertensive heart failure rats using electrospray ionization mass spectrometry. Journal of Lipid Research, 46, 1196-1204.
78. Steward, C.G., Newbury-Ecob, R.A., Hastings, R., Smithson, S.F., Tsai-Goodman, B., Quarrell, O.W., Kulik, W., Wanders, R., Pennock, M., Williams, M., Cresswell, J.L., Gonzalez, I.L. & Brennan, P. (2010) Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenatal Diagnosis, 30, 970-976.
79. Takahashi, K., Tanabe, K., Ohnuki, M., Narita, M., Ichisaka, T., Tomoda, K. & Yamanaka, S. (2007) Induction of pluripotent stem cells from human fibroblasts by defined factors. Cell, 131, 861-872.
80. Tanaka, T., Takahashi, K., Yamane, M., Tomida, S., Nakamura, S., Oshima, K., Niwa, A., Nishikomori, R., Kambe, N., Hara, H., Mitsuyama, M., Morone, N., Heuser, J.E., Yamamoto, T., Watanabe, A., Sato-Otsubo, A., Ogawa, S., Asaka, I., Heike, T., Yamanaka, S., Nakahata, T. & Saito, M.K. (2012) Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery. Blood, 120, 1299-1308.
81. Tommasini, A., Ferrari, S., Moratto, D., Badolato, R., Boniotto, M., Pirulli, D., Notarangelo, L.D. & Andolina, M. (2002) X-chromosome inactivation analysis in a female carrier of FOXP3 mutation. Clinical and Experimental Immunology, 130, 127-130.
82. Valianpour, F., Wanders, R.J., Overmars, H., Vreken, P., Van Gennip, A.H., Baas, F., Plecko, B., Santer, R., Becker, K. & Barth, P.G. (2002) Cardiolipin deficiency in X-linked cardioskeletal myopathy and neutropenia (Barth Syndrome, MIM 302060): a study in cultured skin fibroblasts. Journal of Pediatrics, 141, 729-733.
83. Valianpour, F., Mitsakos, V., Schlemmer, D., Towbin, J.A., Taylor, J.M., Ekert, P.G., Thorburn, D.R., Munnich, A., Wanders, R.J., Barth, P.G. & Vaz, F.M. (2005) Monolysocardiolipins accumulate in Barth syndrome but do not lead to enhanced apoptosis. Journal of Lipid Research, 46, 1182-1195.
84. Vreken, P., Valianpour, F., Nijtmans, L.G., Grivell, L.A., Plecko, B., Wanders, R.J.A. & Barth, P.G. (2000) Defective remodeling of cardiolipin and phosphatidylglycerol in Barth syndrome. Biochemical and Biophysical Research Communications, 279, 378-382.
85. Welte, K., Zeidler, C. & Dale, D.C. (2006) Severe congenital neutropenia. Seminars in Hematology, 43, 189-195.
86. Xu, Y., Condell, M., Plesken, H., Edelman-Novemsky, I., Ma, J., Ren, M. & Schlame, M. (2006) A Drosophila model of Barth syndrome. Proceedings of the National Academy of Sciences of the USA, 103, 11584-11588.
87. Zeidler, C., Barth, P.G., Bonilla, M.A., Bolyard, A.A., Boxer, L., Cottle, T., Dale, D.C., Donadieu, J., Fier, C., Freedman, M., Kannourakis, G., Kinsey, S., Liang, B., Schwinzer, B., Welte, K. & Cham, B. (2001) Neutropenia in Barth syndrome: clinical course and treatment of neutropenia. Blood, 98(Suppl), 300a.